Literature DB >> 33569850

M1 Macrophage exosomes MiR-21a-5p aggravates inflammatory bowel disease through decreasing E-cadherin and subsequent ILC2 activation.

Jiaxi Lu1, Deliang Liu1, Yuyong Tan1, Feihong Deng1, Rong Li1.   

Abstract

Abnormal immune regulation is a key feature of the complex pathogenic mechanism of ulcerative colitis (UC). In particular, macrophages and group 2 innate lymphoid cells (ILC2s) are important components of natural immunity that have been shown to play important roles in the pathogenesis of UC, as well as decreased E-cadherin expression on the colonic mucosa. However, it remains unclear how these components interact with each other. In this study, we investigated the molecular mechanisms of UC mediated by macrophage-derived exosomes. We showed for the first time that miR-21a-5p expression is increased in the peritoneal exosomes of mice with dextran sulphate sodium induced enteritis and that miR-21a-5p expression correlates negatively with E-cadherin expression in enterocytes. Moreover, we confirmed that miR-21a-5p was mainly derived from M1 macrophages and demonstrated that KLRG1, a surface inhibitory receptor on ILC2s, participated in excessive ILC2 activation in UC by promoting GATA-3. In conclusion, our results suggest molecular targets and provide a theoretical basis for elucidating the pathogenesis of UC and improving its treatment.
© 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  E-cadherin; MiR-21a-5p; group 2 innate lymphoid cell; macrophage-derived exosome; ulcerative colitis

Year:  2021        PMID: 33569850      PMCID: PMC7957199          DOI: 10.1111/jcmm.16348

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  34 in total

1.  The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.

Authors:  Yeshan Zhu; Xueqing Li; Jianquan Chen; Tongjun Chen; Zhimin Shi; Miaona Lei; Yanjun Zhang; Pengfei Bai; Yifang Li; Xuan Fei
Journal:  Int Immunopharmacol       Date:  2015-12-03       Impact factor: 4.932

Review 2.  GATA-3 function in innate and adaptive immunity.

Authors:  Irma Tindemans; Nicolas Serafini; James P Di Santo; Rudi W Hendriks
Journal:  Immunity       Date:  2014-08-21       Impact factor: 31.745

3.  Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-α production by interaction with its soluble E-cadherin ligand in chronically inflamed joints.

Authors:  Lode Melis; Liesbet Van Praet; Hanspeter Pircher; Koen Venken; Dirk Elewaut
Journal:  Ann Rheum Dis       Date:  2013-06-05       Impact factor: 19.103

4.  A Major Population of Functional KLRG1- ILC2s in Female Lungs Contributes to a Sex Bias in ILC2 Numbers.

Authors:  Sapana Kadel; Erola Ainsua-Enrich; Ibrahim Hatipoglu; Sean Turner; Simar Singh; Sohaib Khan; Susan Kovats
Journal:  Immunohorizons       Date:  2018-02

Review 5.  Ulcerative colitis.

Authors:  Ryan Ungaro; Saurabh Mehandru; Patrick B Allen; Laurent Peyrin-Biroulet; Jean-Frédéric Colombel
Journal:  Lancet       Date:  2016-12-01       Impact factor: 79.321

6.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity.

Authors:  Daniel R Neill; See Heng Wong; Agustin Bellosi; Robin J Flynn; Maria Daly; Theresa K A Langford; Christine Bucks; Colleen M Kane; Padraic G Fallon; Richard Pannell; Helen E Jolin; Andrew N J McKenzie
Journal:  Nature       Date:  2010-03-03       Impact factor: 49.962

7.  Th1/Th2 Balance and Th17/Treg-Mediated Immunity in relation to Murine Resistance to Dextran Sulfate-Induced Colitis.

Authors:  Fangli Yang; Danan Wang; Yan Li; Lixuan Sang; Junfeng Zhu; Jinyan Wang; Bing Wei; Changlong Lu; Xun Sun
Journal:  J Immunol Res       Date:  2017-05-11       Impact factor: 4.818

8.  KLRG1 and NKp46 discriminate subpopulations of human CD117+CRTH2- ILCs biased toward ILC2 or ILC3.

Authors:  Maho Nagasawa; Balthasar A Heesters; Chantal M A Kradolfer; Lisette Krabbendam; Itziar Martinez-Gonzalez; Marjolein J W de Bruijn; Korneliusz Golebski; Rudi W Hendriks; Ralph Stadhouders; Hergen Spits; Suzanne M Bal
Journal:  J Exp Med       Date:  2019-06-14       Impact factor: 14.307

9.  M1 Macrophage exosomes MiR-21a-5p aggravates inflammatory bowel disease through decreasing E-cadherin and subsequent ILC2 activation.

Authors:  Jiaxi Lu; Deliang Liu; Yuyong Tan; Feihong Deng; Rong Li
Journal:  J Cell Mol Med       Date:  2021-02-10       Impact factor: 5.310

10.  Restoring Mucosal Barrier Function and Modifying Macrophage Phenotype with an Extracellular Matrix Hydrogel: Potential Therapy for Ulcerative Colitis.

Authors:  Timothy J Keane; Jenna Dziki; Eric Sobieski; Adam Smoulder; Arthur Castleton; Neill Turner; Lisa J White; Stephen F Badylak
Journal:  J Crohns Colitis       Date:  2017-03-01       Impact factor: 9.071

View more
  9 in total

Review 1.  Macrophage-Derived Small Extracellular Vesicles in Multiple Diseases: Biogenesis, Function, and Therapeutic Applications.

Authors:  Jingyao Ye; Xuehong Liu
Journal:  Front Cell Dev Biol       Date:  2022-06-27

Review 2.  The Role of Tissue-Resident Macrophages in the Development and Treatment of Inflammatory Bowel Disease.

Authors:  Shengjie Ma; Jiaxin Zhang; Heshi Liu; Shuang Li; Quan Wang
Journal:  Front Cell Dev Biol       Date:  2022-05-26

Review 3.  Heterogeneity of ILC2s in the Intestine; Homeostasis and Pathology.

Authors:  Shogo Sunaga; Junya Tsunoda; Toshiaki Teratani; Yohei Mikami; Takanori Kanai
Journal:  Front Immunol       Date:  2022-05-30       Impact factor: 8.786

4.  M1 Macrophage exosomes MiR-21a-5p aggravates inflammatory bowel disease through decreasing E-cadherin and subsequent ILC2 activation.

Authors:  Jiaxi Lu; Deliang Liu; Yuyong Tan; Feihong Deng; Rong Li
Journal:  J Cell Mol Med       Date:  2021-02-10       Impact factor: 5.310

Review 5.  The Immuno-Modulation Effect of Macrophage-Derived Extracellular Vesicles in Chronic Inflammatory Diseases.

Authors:  Yi Xing; Xun Sun; Yiming Dou; Min Wang; Yanmei Zhao; Qiang Yang; Yanhong Zhao
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

6.  Syndecan-1 Shedding by Matrix Metalloproteinase-9 Signaling Regulates Alveolar Epithelial Tight Junction in Lipopolysaccharide-Induced Early Acute Lung Injury.

Authors:  Dong Zhang; Jin-Tao Zhang; Yun Pan; Xiao-Fei Liu; Jia-Wei Xu; Wen-Jing Cui; Xin-Rui Qiao; Liang Dong
Journal:  J Inflamm Res       Date:  2021-11-04

Review 7.  The Extracellular MicroRNAs on Inflammation: A Literature Review of Rodent Studies.

Authors:  Seri Lee; Jade Heejae Ko; Seung-Nam Kim
Journal:  Biomedicines       Date:  2022-07-05

Review 8.  Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease.

Authors:  De-Feng Li; Mei-Feng Yang; Jing Xu; Hao-Ming Xu; Min-Zheng Zhu; Yu-Jie Liang; Yuan Zhang; Cheng-Mei Tian; Yu-Qiang Nie; Rui-Yue Shi; Li-Sheng Wang; Jun Yao
Journal:  Int J Nanomedicine       Date:  2022-09-05

Review 9.  The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability.

Authors:  Sarah Stiegeler; Kevin Mercurio; Miruna Alexandra Iancu; Sinéad C Corr
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.